This is the authors' abstract. We don't add key points for this paper.
A rapid and efficient gamma radiation-driven method was developed to fabricate sodium hyaluronate-functionalized selenium nanohybrids (SeNHs@HA) for targeted delivery of camptothecin (CPT), aiming to improve selectivity, therapeutic efficacy, and safety. Sodium hyaluronate (HA) was employed as a stabilizing, capping and surface functionalizing agent for SeNPs, leading to the formation of SeNHs@HA. Key parameters, including pH, HA concentration and gamma irradiation dose, were systematically optimized to precisely control particle size, morphology, and surface characteristics. Under optimized conditions, core-shell structured SeNHs@HA were successfully synthesized via a green approach and exhibited a uniform, monodispersed spherical morphology with an average diameter of 64.10 nm. The hydrophobic CPT was efficiently encapsulated within the multifunctional nanocarrier, resulting in enlarged CPT-SeNHs@HA nanostructures with improved physicochemical properties, enhanced cellular uptake, and increased targeting capability. The nanohybrids demonstrated a distinct pH-responsive release behavior, with accelerated drug release under acidic conditions, reaching 74.58% at 72 h. Cytotoxicity studies demonstrated significantly enhanced anticancer activity against MCF-7 cells (IC 50 =0.79 µM), representing a 5.96-fold improvement over free CPT (IC 50 =4.71 µM). Additionally, the system induced early apoptosis (32.91%) and S-phase cell cycle arrest. These findings highlight smart CPT-SeNHs@HA as a promising platform for targeted breast cancer drug delivery system.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Laksee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: